Efficacy and safety of continuing sitagliptin when initiating insulin therapy in subjects with type 2 diabetes

被引：0
|
作者：
Roussel, R. [1 ]
Duran-Garcia, S. [2 ]
Zhang, Y. [3 ]
Shah, S. [3 ]
Darmiento, C. [3 ]
Shankar, R. R. [3 ]
O'Neill, E. A. [3 ]
Golm, G. T. [3 ]
Lam, R. L. H. [3 ]
Gantz, I. [3 ]
Kaufman, K. D. [3 ]
Engel, S. S. [3 ]
机构：
[1] Grp Hosp Bichat, Paris, France
[2] Valme Univ Hosp, Med Sch, Seville, Spain
[3] Merck & Co Inc, Kenilworth, NJ USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
770
引用
收藏
页码：S378 / S378
页数：1
相关论文
共 50 条
  • [31] A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes
    Shankar, R. Ravi
    Zeitler, Philip
    Deeb, Asma
    Jalaludin, Muhammad Yazid
    Garcia, Raymundo
    Newfield, Ron S.
    Samoilova, Yulia
    Rosario, Carmen A.
    Shehadeh, Naim
    Saha, Chandan K.
    Zhang, Yilong
    Zilli, Martina
    Scherer, Lynn W.
    Lam, Raymond L. H.
    Golm, Gregory T.
    Engel, Samuel S.
    Kaufman, Keith D.
    PEDIATRIC DIABETES, 2022, 23 (02) : 173 - 182
  • [32] Continuation versus discontinuation of insulin secretagogues when initiating insulin in type 2 diabetes
    Swinnen, S. G.
    Dain, M. -P.
    Mauricio, D.
    DeVries, J. H.
    Hoekstra, J. B.
    Holleman, F.
    DIABETES OBESITY & METABOLISM, 2010, 12 (10): : 923 - 925
  • [33] Efficacy and safety of sitagliptin added to metformin and insulin compared with voglibose in patients with newly diagnosed type 2 diabetes
    Shi, Chunhong
    Zhang, Ru
    Bai, Ran
    Liu, Dan
    Wang, Yongbo
    Zhang, Xueyang
    Wang, Hao
    Du, Jianling
    CLINICS, 2019, 74
  • [34] Initiating insulin therapy in type 2 diabetes: Benefits of insulin analogs and insulin pens
    Brunton, Stephen
    DIABETES TECHNOLOGY & THERAPEUTICS, 2008, 10 (04) : 247 - 256
  • [35] THE EFFICACY OF SITAGLIPTIN ON INSULIN TREATMENT FOR JAPANESE PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Matsuhashi, Y.
    Chikazawa, S.
    Matsui, J.
    Daimon, M.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S142 - S142
  • [36] Improved efficacy when insulin detemir is added to OADs in Indian subjects with type 2 diabetes
    Ambady, Ramachandran
    Kumar, Fiarish
    Annamalai, Sundaram
    Patel, Mayur
    Gupta, Sunil
    Venkatanarasimhachar, Srishyla M.
    DIABETES, 2006, 55 : A469 - A470
  • [37] Initiating insulin in type 2 diabetes
    Ravina, A
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2004, 6 (12): : 787 - 787
  • [38] Initiating insulin in type 2 diabetes
    Dailey, George
    DRUG DEVELOPMENT RESEARCH, 2008, 69 (03) : 116 - 118
  • [39] Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency
    Chan, J. C. N.
    Scott, R.
    Ferreira, J. C. Arjona
    Sheng, D.
    Gonzalez, E.
    Davies, M. J.
    Stein, P. P.
    Kaufman, K. D.
    Amatruda, J. M.
    Williams-Herman, D.
    DIABETES OBESITY & METABOLISM, 2008, 10 (07): : 545 - 555
  • [40] Effect of Sitagliptin Added On to Insulin Glargine and Metformin in Obese Subjects with Diabetes Type 2
    Zivkovic, Teodora Beljic
    Petkovic, Milica Marjanovic
    Soldatovic, Ivan
    Kanlic, Dobrila
    Vuksanovic, Miljanka
    Topalov, Drina
    DIABETES, 2014, 63 : A598 - A598
12345